BioAge Labs Inc.
BIOA | NASDAQ
$8.46
+$0.37 (+4.57%)
At close: Sep 22, 2026, 4:00 PM ET
$8.49
+$0.03 (+0.35%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $304.59M
Enterprise Value $-11.32M
Beta 0.94
Average Volume 723.55K
Shares Outstanding (Diluted) 44.84M
Shares Change YoY 25.07%
Institutional Ownership 80.72%
Exchange NASDAQ
ISIN US09077V1008
Price Performance
Price Change 1M -15.4%
Price Change 3M -63.8%
Price Change 6M -50.7%
Price Change YTD -36.9%
Price Change 1Y 58.3%
Price Change 3Y -61.5%
Price Change 5Y -61.5%
1M CAGR (ann.) -31.0%
1Y CAGR (ann.) 55.0%
5Y CAGR (ann.) N/A
All-Time CAGR -33.7%
Valuation
PE Ratio -3.40
Forward PE N/A
PEG Ratio 0.46
Forward PEG 0.32
PS Ratio 29.41
Forward PS 19.40
PB Ratio 0.81
P/FCF Ratio -2.72
P/Adj. FCF Ratio -2.33
P/OCF Ratio -4.15
EV/Sales -1.09
EV/EBIT 0.11
EV/EBITDA 0.11
EV/FCF 0.10
Earnings Yield -29.4%
FCF Yield -36.8%
Adj. FCF Yield -42.8%
Financial Health
Net Cash $318.03M
Total Debt $2.84M
Cash & Short-Term Investments $318.75M
Total Assets $396.93M
Current Ratio 17.19
Quick Ratio 17.19
Debt / Equity Ratio 0.01
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -39.38
Interest Coverage -378.19
Altman Z-Score 7.08
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 99.4%
Operating Profit Margin -1026.3%
EBITDA Margin -907.1%
Net Profit Margin -912.3%
FCF Margin -1083.2%
Adj. FCF Margin -1259.8%
SBC / Revenue 135.6%
SBC Impact (per share) -16.3%
Returns
Return on Assets -23.8%
Return on Equity -29.0%
Return on Invested Capital -28.1%
Return on Capital Employed -28.1%
Return on Tangible Assets -23.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 109.3%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -13.1%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -44.2%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y -7.1%
Revenue Growth Next 3Y -25.1%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.66
EPS Growth Est (next Q) 17.9%
Revenue Est (next Q) $1.53M
Revenue Growth Est (next Q) -25.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $34
Price Target Upside 320.3%
Cash Flow
Operating Cash Flow $-111.65M
Free Cash Flow $-112.16M
Adj. Free Cash Flow $-130.46M
FCF Per Share -$1.96
OCF Per Share -$1.95
OCF/S Ratio -846.0%
Income Statement
Revenue $10.36M
Gross Profit $10.29M
Operating Income $-106.27M
EBITDA $-100.48M
Net Income $-94.46M
EPS (Diluted) -$2.38
Revenue / Employee $169.75K
Profit / Employee $-1.55M
Employees 61
Add to Watchlist
Select watchlists to add or remove BIOA